Patient information (specimens in final analysis)
Specimens/characteristic . | Value . |
---|---|
Total, N | 172 |
AML | 108 |
ALL | 28 |
CD34+ cells | 21 |
White blood cells | 15 |
ALL | |
Primary diagnosis specimens, n | 28 |
Mean age, y (range) | 8.7 (1-17) |
Sex, male/female | 12/6 |
Mean white blood cells, ×103/μL (range) | 77 (1.7-574) |
Immunophenotype, n | |
c-ALL | 17 |
Pre–B-ALL | 4 |
Pro–B-ALL | 6 |
T-ALL | 1 |
Balanced translocations, n | |
t(9;22) | 2 |
t(4;11) | 4 |
t(12;21) | 3 |
AML | |
Specimens, n | |
Primary diagnosis | 100 |
Relapse or refractory | 8 |
Mean age, y (range) | 54 (17-79) |
Sex, male/female | 65/43 |
Mean hemoglobin, g/dL (range) | 9.3 (5.2-14.3) |
Mean platelets, ×103/μL (range) | 60 (7-656) |
Mean white blood cells, ×103/μL (range) | 61 (0.4-935) |
Karyotype, n | |
Normal | 36 |
Complex karyotype | 17 |
inv(16) | 11 |
t(15;17) | 13 |
t(8;21) | 10 |
Others/not determined | 21 |
FLT3-ITD mutation | 18 |
NPM1 mutation | 10 |
Specimens/characteristic . | Value . |
---|---|
Total, N | 172 |
AML | 108 |
ALL | 28 |
CD34+ cells | 21 |
White blood cells | 15 |
ALL | |
Primary diagnosis specimens, n | 28 |
Mean age, y (range) | 8.7 (1-17) |
Sex, male/female | 12/6 |
Mean white blood cells, ×103/μL (range) | 77 (1.7-574) |
Immunophenotype, n | |
c-ALL | 17 |
Pre–B-ALL | 4 |
Pro–B-ALL | 6 |
T-ALL | 1 |
Balanced translocations, n | |
t(9;22) | 2 |
t(4;11) | 4 |
t(12;21) | 3 |
AML | |
Specimens, n | |
Primary diagnosis | 100 |
Relapse or refractory | 8 |
Mean age, y (range) | 54 (17-79) |
Sex, male/female | 65/43 |
Mean hemoglobin, g/dL (range) | 9.3 (5.2-14.3) |
Mean platelets, ×103/μL (range) | 60 (7-656) |
Mean white blood cells, ×103/μL (range) | 61 (0.4-935) |
Karyotype, n | |
Normal | 36 |
Complex karyotype | 17 |
inv(16) | 11 |
t(15;17) | 13 |
t(8;21) | 10 |
Others/not determined | 21 |
FLT3-ITD mutation | 18 |
NPM1 mutation | 10 |